Ads
related to: dana farber cancer institute researchAACR.org has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
In 2000, Wu joined the Dana-Farber faculty and began her independent research program in 2005. [1]In 2011, Wu was the recipient of a Stand Up To Cancer Innovative Research Grant for her project "Coupled Genetic and Functional Dissection of Chronic Lymphocytic Leukemia."
Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility. He is currently the director of the Center for DNA Damage and Repair and the ...
Still, researchers have wondered if women truly benefit from this treatment, said Dr. Ann Partridge, interim chair of medical oncology at the Dana-Farber Cancer Institute and another lead author ...
2 Career and research interests. 3 Recognition. 4 ... Gordon J. Freeman is an American immunologist and oncologist at the Dana-Farber Cancer Institute and Harvard ...
Dana–Farber Cancer Institute Harvard Medical School: 2014 Kenneth W. Kinzler, PhD Johns Hopkins Kimmel Cancer Center: 2014 Richard Kolodner, PhD Ludwig Institute for Cancer Research: 2014 Ronald Levy, MD Stanford University School of Medicine: 2014 Frederick Pei Li, MD Deceased (1940-2015) 2014 David M. Livingston, MD Dana–Farber Cancer ...
Irene Ghobrial is an American-Egyptian physician who is a professor at the Dana–Farber Cancer Institute [2] and Harvard Medical School, [1] [3] where her research investigates early detection, mechanisms of disease progression and early interception of multiple myeloma.
John Quackenbush is an American computational biologist and genome scientist.He is a professor of biostatistics and computational biology and a professor of cancer biology at the Dana–Farber Cancer Institute (DFCI), [1] [2] [3] as well as the director of its Center for Cancer Computational Biology (CCCB). [4]
Ads
related to: dana farber cancer institute researchAACR.org has been visited by 10K+ users in the past month